Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IntermesticTSE:262A -1.68%16 Market Cap is 円56,614 Mil as of Aug. 28, 2026. GuruFocus rates TSE:262A with a GF Score™ of 16/100. The stock has 4 warning signs investors should review. Among 861 Medical Devices & Instruments companies, Intermestic ranks better than 62.95% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Intermestic's share price for the quarter that ended in Jun. 2026 was 円2042. Intermestic's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 31 Mil. Therefore, Intermestic's market cap for the quarter that ended in Jun. 2026 was 円62,612 Mil.
Intermestic's quarterly market cap
declined
from Dec. 2025 (円59,792 Mil) to Mar. 2026 (円56,212 Mil) but then
increased
from Mar. 2026 (円56,212 Mil) to Jun. 2026 (円62,612 Mil).
Intermestic's annual market cap
increased
from Dec. 2023 (円0 Mil) to Dec. 2024 (円79,193 Mil) but then
declined
from Dec. 2024 (円79,193 Mil) to Dec. 2025 (円59,792 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Intermestic's Enterprise Value for Today is 円64,905 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Intermestic Market Cap Related Terms
Intermestic Market Cap Historical Data
* Premium members only.
The historical data trend for Intermestic's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:262A vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Intermestic's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intermestic Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intermestic's Market Cap distribution charts can be found below:
* The bar in red indicates where Intermestic's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Intermestic's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intermestic (TSE:262A) has a Market Cap of 円56,614 Mil as of Aug. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Intermestic and its competitors. According to the industry distribution chart, Intermestic ranks #319 out of 861 companies in the Medical Devices & Instruments industry, placing it in the top 37%.
Is Intermestic's Market Cap too high?
Intermestic's current Market Cap is 円56,614 Mil. Based on the distribution chart, Intermestic ranks #319 out of 861 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Intermestic has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Intermestic's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Intermestic ranks #319 out of 861 companies for Market Cap. This puts Intermestic in the upper half of its industry. The industry median Market Cap is 125.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 125.09, based on 861 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Intermestic and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 125.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intermestic's current Market Cap is 円56,614 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intermestic stock overvalued right now?
Intermestic (TSE:262A) has a current Market Cap of 円56,614 Mil. The current Market Cap is 円56,614 Mil. Intermestic's overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Intermestic (TSE:262A), the current Market Cap is 円56,614 Mil as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:262A has been successfully added to your 
